4//SEC Filing
Townsend Adam J. 4
Accession 0001127602-25-001203
CIK 0001492422other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:29 PM ET
Size
4.7 KB
Accession
0001127602-25-001203
Insider Transaction Report
Form 4
Townsend Adam J.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-01-13$28.70/sh−2,685$77,065→ 90,269 total
Footnotes (2)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 10, 2025.
- [F2]This includes 501 shares from April 30, 2024 ESPP purchase.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001773588
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 4:29 PM ET
- Size
- 4.7 KB